EP-1616 Population-based Phase II Trial of Stereotactic Radiotherapy for up to 5 Oligometastases: SABR-5. (April 2019) - Olson, R.; Liu, M.; Bergman, A.; Lam, S.; Hsu, F.; Mou, B.; Berrang, T.; Mestrovic, A.; Chng, N.; Hyde, D.; Matthews, Q.; Lund, C.; et al.